Study challenges the idea of region-specific HIV vaccines
South African volunteers’ immune systems respond well to an experimental preventive shot against the virus that causes Aids developed in Thailand
18 September 2019 - 20:00
An experimental HIV vaccine first tested in Thailand has triggered a surprisingly strong immune response in South African volunteers, though the region is home to a different strain of the virus, research published this week in the international peer review journal, Science Translational Medicine, shows.
SA has the world’s highest HIV burden with more than 7-million infections, which are dominated by clade C infections. In Thailand, the dominant strains is clade B...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.